Drug General Information
Drug ID	D01GVC
Former ID	DIB002166
Drug Name	GP-3269
Synonyms	GP-1-3269
Indication	Convulsions [ICD9: 780.3; ICD10:R56.0]		Phase 1	[527887]
Company	Metabasis Therapeutics Inc
Structure		Download 2D MOL 3D MOL
Canonical SMILES	n1(c2c(c(c1)c1ccccc1)c(ncn2)Nc1ccc(F)cc1)[C@H]1[C@@H]([<br />C@@H]([C@H](O1)C)O)O
CAS Number	CAS 186393-42-0
Target and Pathway
Target(s)	Adenosine kinase	Target Info	Inhibitor	[527887]
BioCyc Pathway	Superpathway of purine nucleotide salvage
	Adenine and adenosine salvage II
KEGG Pathway	Purine metabolism
	Metabolic pathways
Reactome	Purine salvage
WikiPathways	Metabolism of nucleotides
References
Ref 527887	Adenosine kinase inhibitors. 6. Synthesis, water solubility, and antinociceptive activity of 5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidines substituted at C4 with glycinamides andrelated compounds. J Med Chem. 2005 Dec 1;48(24):7808-20.
Ref 527887	Adenosine kinase inhibitors. 6. Synthesis, water solubility, and antinociceptive activity of 5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidines substituted at C4 with glycinamides andrelated compounds. J Med Chem. 2005 Dec 1;48(24):7808-20.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.